{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:28:29Z","timestamp":1764131309904},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/fbp.0b013e32832a805e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:26:17Z","timestamp":1242901577000},"page":"166-173","source":"Crossref","is-referenced-by-count":7,"title":["Interferon-alpha reinstates morphine-conditioned place preference through opioid receptors in rats"],"prefix":"10.1097","volume":"20","author":[{"given":"Jun-Yuan","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s004290050044","article-title":"Localization of 2\u2032,5\u2032-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-alpha A\/D in the mouse brain","volume":"195","author":"Asada-Kubota","year":"1997","journal-title":"Anat Embryol (Berl)"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinthera.2007.01.009","article-title":"Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment","volume":"29","author":"Berk","year":"2007","journal-title":"Clin Ther"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-4328(03)00071-8","article-title":"Chronic interferon-alpha potentiates latent inhibition in rats","volume":"144","author":"Bethus","year":"2003","journal-title":"Behav Brain Res"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1073\/pnas.77.10.5972","article-title":"Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins","volume":"77","author":"Blalock","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0006-291X(81)91284-5","article-title":"Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity","volume":"101","author":"Blalock","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"R7-5-20210202","first-page":"235","article-title":"Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats","volume":"4","author":"Dafny","year":"1983a","journal-title":"Neurotoxicology"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0028-3908(83)90157-0","article-title":"Interferon modifies morphine withdrawal phenomena in rodents","volume":"22","author":"Dafny","year":"1983b","journal-title":"Neuropharmacology"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0024-3205(83)90074-7","article-title":"Modification of morphine withdrawal by interferon","volume":"32","author":"Dafny","year":"1983c","journal-title":"Life Sci"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0278-5846(84)80021-4","article-title":"Interferon: a candidate as the endogenous substance preventing tolerance and dependence to brain opioids","volume":"8","author":"Dafny","year":"1984","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3109\/00207458709043352","article-title":"Single injection of three different preparations of alpha-interferon modifies morphine abstinence signs for a prolonged period","volume":"32","author":"Dafny","year":"1987","journal-title":"Int J Neurosci"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.08.029","article-title":"Interferon and the central nervous system","volume":"523","author":"Dafny","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0143-4179(83)90036-7","article-title":"Alteration of morphine withdrawal to naloxone by interferon","volume":"3","author":"Dafny","year":"1983","journal-title":"Neuropeptides"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jnr.490190118","article-title":"Immune response products alter CNS activity: interferon modulates central opioid functions","volume":"19","author":"Dafny","year":"1988","journal-title":"J Neurosci Res"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(03)02757-4","article-title":"The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus","volume":"977","author":"De La Garza","year":"2003","journal-title":"Brain Res"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00433012","article-title":"Drug reinstatement of heroin-reinforced responding in the rat","volume":"79","author":"De Wit","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review","volume":"157","author":"Dieperink","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/0028-3908(87)90007-4","article-title":"Differential modification of morphine and methadone dependence by interferon alpha","volume":"26","author":"Dougherty","year":"1987","journal-title":"Neuropharmacology"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.1997.8661","article-title":"Evidence for induction of interferon-alpha and interferon-beta in retinal glial cells of Muller","volume":"234","author":"Drescher","year":"1997","journal-title":"Virology"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/brbi.1993.1011","article-title":"Repeated injections of interferon-alpha A\/D in Balb\/c mice: behavioral effects","volume":"7","author":"Dunn","year":"1993","journal-title":"Brain Behav Immun"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2007.05.005","article-title":"The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats","volume":"182","author":"Fahey","year":"2007","journal-title":"Behav Brain Res"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in d\u00e9tente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00001813-199402000-00014","article-title":"The opioid mechanism of interferon-alpha action","volume":"5","author":"Ho","year":"1994","journal-title":"Anticancer Drugs"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1128\/JVI.00530-07","article-title":"Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo","volume":"81","author":"Jewell","year":"2007","journal-title":"J Virol"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0197-0186(99)00124-2","article-title":"Analgesic effect of interferon-alpha via mu opioid receptor in the rat","volume":"36","author":"Jiang","year":"2000","journal-title":"Neurochem Int"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0306-4522(03)00365-8","article-title":"Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue","volume":"120","author":"Katafuchi","year":"2003","journal-title":"Neuroscience"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1111\/j.1460-9568.2005.04478.x","article-title":"Enhanced expression of brain interferon-alpha and serotonin transporter in immunologically induced fatigue in rats","volume":"22","author":"Katafuchi","year":"2005","journal-title":"Eur J Neurosci"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.10.033","article-title":"Investigating the hedonic effects of interferon-alpha on female rats using brain-stimulation reward","volume":"177","author":"Kentner","year":"2007","journal-title":"Behav Brain Res"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000104884","article-title":"Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study","volume":"13","author":"Krook","year":"2007","journal-title":"Eur Addict Res"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/IAI.22.3.786-789.1978","article-title":"Interferon production in glia and glioma cell lines","volume":"22","author":"Larsson","year":"1978","journal-title":"Infect Immun"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/520093","article-title":"Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication","volume":"196","author":"Li","year":"2007","journal-title":"J Infect Dis"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00213-005-2207-5","article-title":"Role of withdrawal in reinstatement of morphine-conditioned place preference","volume":"181","author":"Lu","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R34-5-20210202","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0006-8993(99)02235-0","article-title":"Human interferon-alpha induces immobility in the mouse forced swimming test: involvement of the opioid system","volume":"852","author":"Makino","year":"2000a","journal-title":"Brain Res"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjp.0703432","article-title":"Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test","volume":"130","author":"Makino","year":"2000b","journal-title":"Br J Pharmacol"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"L227","DOI":"10.1016\/0024-3205(92)90555-4","article-title":"Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes","volume":"50","author":"Menzies","year":"1992","journal-title":"Life Sci"},{"key":"R38-5-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-4328(00)00239-4","article-title":"Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction","volume":"115","author":"Mueller","year":"2000","journal-title":"Behav Brain Res"},{"key":"R39-5-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0361-9230(94)00259-2","article-title":"Naloxone suppresses the rising phase of fever induced by interferon-alpha","volume":"37","author":"Nakashima","year":"1995","journal-title":"Brain Res Bull"},{"key":"R40-5-20210202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(98)04793-X","article-title":"Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders","volume":"354","author":"Pariante","year":"1999","journal-title":"Lancet"},{"key":"R41-5-20210202","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(00)00222-7","article-title":"Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes","volume":"66","author":"Parker","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"R42-5-20210202","article-title":"The rat brain in stereotaxic coordinates. 2nd ed","author":"Paxinos","year":"1997"},{"key":"R43-5-20210202","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"R44-5-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0149-7634(05)80001-6","article-title":"Immunoregulators in the nervous system","volume":"15","author":"Plata-Salaman","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"R45-5-20210202","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/brbi.1995.1034","article-title":"A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia","volume":"9","author":"Rho","year":"1995","journal-title":"Brain Behav Immun"},{"key":"R46-5-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pbb.2007.09.013","article-title":"Alpha-2 agonists decrease expression of morphine-induced conditioned place preference","volume":"88","author":"Samini","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R47-5-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4615-1951-5_29","article-title":"Neuroendocrine effects of interferon-alpha in the rat","volume":"373","author":"Saphier","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"R48-5-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/brbi.1994.1004","article-title":"Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat","volume":"8","author":"Saphier","year":"1994","journal-title":"Brain Behav Immun"},{"key":"R49-5-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02246022","article-title":"Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats","volume":"125","author":"Shaham","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"R50-5-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"R51-5-20210202","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0091-3057(84)90017-0","article-title":"Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area","volume":"20","author":"Stewart","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"R52-5-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02245289","article-title":"Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction","volume":"108","author":"Stewart","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"R53-5-20210202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clpt.2004.09.008","article-title":"Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy","volume":"77","author":"Sulkowski","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R54-5-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: an interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"R55-5-20210202","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","article-title":"Morphine withdrawal enhances hepatitis C virus replicon expression","volume":"167","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"R56-5-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.mp.4002013","article-title":"Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system","volume":"13","author":"Wang","year":"2008","journal-title":"Mol Psychiatry"},{"key":"R57-5-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(01)01487-X","article-title":"Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats","volume":"432","author":"Wang","year":"2001a","journal-title":"Eur J Pharmacol"},{"key":"R58-5-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00001756-200103260-00046","article-title":"Analgesic domains of interferon-alpha","volume":"12","author":"Wang","year":"2001b","journal-title":"Neuroreport"},{"key":"R59-5-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0165-5728(00)00271-X","article-title":"Distinct domains of IFNalpha mediate immune and analgesic effects respectively","volume":"108","author":"Wang","year":"2000","journal-title":"J Neuroimmunol"},{"key":"R60-5-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-007-0893-x","article-title":"Conditioned drug reward enhances subsequent spatial learning and memory in rats","volume":"195","author":"Zhai","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R61-5-20210202","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/WNR.0b013e3281ac212e","article-title":"Effects of stress during reactivation on rewarding memory","volume":"18","author":"Zhao","year":"2007","journal-title":"Neuroreport"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008877-200903000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:40:22Z","timestamp":1618364422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-200903000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e32832a805e","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}